Nilutamide
NDC 62559-173, Nilutamide, tablet, from ANI Pharmaceuticals, Inc..
- Product NDC
- 62559-173
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207631
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62559-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NILUTAMIDE150 mg/1
Pharmacologic classes
Androgen Receptor Antagonists [MoA]; Androgen Receptor Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62559-173-31 | 62559017331 | 3 BLISTER PACK in 1 CARTON (62559-173-31) / 10 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d5740b8f-fbb3-4023-9133-9e359a9ab980
Use it
Look up 62559-173 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62559-173 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62559-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.